Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1621 to 165 of 165 entries
Sorted by: Best Match Show Resources per page
Filters applied: Corrected and Republished Article
Buprenorphine Implants (Probuphine) for Opioid Dependence.

JAMA

[No authors listed]
PMID: 27802544
JAMA. 2016 Nov 01;316(17):1820-1821. doi: 10.1001/jama.2016.10899.

No abstract available.

Cite
Buprenorphine Implants (Probuphine) for Opioid Dependence. JAMA. 2016;316(17):1820-1821doi: 10.1001/jama.2016.10899.
(2016). Buprenorphine Implants (Probuphine) for Opioid Dependence. JAMA, 316(17), 1820-1821. https://doi.org/10.1001/jama.2016.10899
"Buprenorphine Implants (Probuphine) for Opioid Dependence." JAMA vol. 316,17 (2016): 1820-1821. doi: https://doi.org/10.1001/jama.2016.10899
Buprenorphine Implants (Probuphine) for Opioid Dependence. JAMA. 2016 Nov 01;316(17):1820-1821. doi: 10.1001/jama.2016.10899. PMID: 27802544.
Copy Download .nbib Format: NLM
Quantitative assessment of tumor-associated tissue eosinophilia and mast cells in tumor proper and lymph nodes of oral squamous cell carcinoma.

Journal of oral and maxillofacial pathology : JOMFP

Jain S, Phulari RG, Rathore R, Shah AK, Sancheti S.
PMID: 30158776
J Oral Maxillofac Pathol. 2018 May-Aug;22(2):227-233. doi: 10.4103/jomfp.JOMFP_170_18.

BACKGROUND: Oral squamous cell carcinoma (OSCC) is the most common cancer of the oral cavity. Tumor stage, thickness, lymph node metastasis (LNM), extranodal spread, perineural invasion, tumor differentiation, mutations, human papillomavirus infection and tumor microenvironment are independent prognostic indicators...

Cite
Jain S, Phulari RG, Rathore R, et al. Quantitative assessment of tumor-associated tissue eosinophilia and mast cells in tumor proper and lymph nodes of oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2018;22(2):227-233doi: 10.4103/jomfp.JOMFP_170_18.
Jain, S., Phulari, R. G., Rathore, R., Shah, A. K., & Sancheti, S. (2018). Quantitative assessment of tumor-associated tissue eosinophilia and mast cells in tumor proper and lymph nodes of oral squamous cell carcinoma. Journal of oral and maxillofacial pathology : JOMFP, 22(2), 227-233. https://doi.org/10.4103/jomfp.JOMFP_170_18
Jain, Shivani, et al. "Quantitative assessment of tumor-associated tissue eosinophilia and mast cells in tumor proper and lymph nodes of oral squamous cell carcinoma." Journal of oral and maxillofacial pathology : JOMFP vol. 22,2 (2018): 227-233. doi: https://doi.org/10.4103/jomfp.JOMFP_170_18
Jain S, Phulari RG, Rathore R, Shah AK, Sancheti S. Quantitative assessment of tumor-associated tissue eosinophilia and mast cells in tumor proper and lymph nodes of oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2018 May-Aug;22(2):227-233. doi: 10.4103/jomfp.JOMFP_170_18. PMID: 30158776; PMCID: PMC6097365.
Copy Download .nbib Format: NLM
Corrected and Republished from: BCL11A Is a Critical Component of a Transcriptional Network That Activates RAG Expression and V(D)J Recombination.

Molecular and cellular biology

Lee BS, Lee BK, Iyer VR, Sleckman BP, Shaffer AL, Ippolito GC, Tucker HO, Dekker JD.
PMID: 29038163
Mol Cell Biol. 2017 Dec 13;38(1). doi: 10.1128/MCB.00362-17. Print 2018 Jan 01.

Recombination activating gene 1 (RAG1) and RAG2 are critical enzymes for initiating variable-diversity-joining [V(D)J] segment recombination, an essential process for antigen receptor expression and lymphocyte development. The BCL11A transcription factor is required for B cell and plasmacytoid dendritic cell...

Cite
Lee BS, Lee BK, Iyer VR, et al. Corrected and Republished from: BCL11A Is a Critical Component of a Transcriptional Network That Activates RAG Expression and V(D)J Recombination. Mol Cell Biol. 2017;38(1)doi: 10.1128/MCB.00362-17.
Lee, B. S., Lee, B. K., Iyer, V. R., Sleckman, B. P., Shaffer, A. L., Ippolito, G. C., Tucker, H. O., & Dekker, J. D. (2018). Corrected and Republished from: BCL11A Is a Critical Component of a Transcriptional Network That Activates RAG Expression and V(D)J Recombination. Molecular and cellular biology, 38(1), . https://doi.org/10.1128/MCB.00362-17
Lee, Baeck-Seung, et al. "Corrected and Republished from: BCL11A Is a Critical Component of a Transcriptional Network That Activates RAG Expression and V(D)J Recombination." Molecular and cellular biology vol. 38,1 (2018). doi: https://doi.org/10.1128/MCB.00362-17
Lee BS, Lee BK, Iyer VR, Sleckman BP, Shaffer AL, Ippolito GC, Tucker HO, Dekker JD. Corrected and Republished from: BCL11A Is a Critical Component of a Transcriptional Network That Activates RAG Expression and V(D)J Recombination. Mol Cell Biol. 2017 Dec 13;38(1). doi: 10.1128/MCB.00362-17. Print 2018 Jan 01. PMID: 29038163; PMCID: PMC5730723.
Copy Download .nbib Format: NLM
El efecto de la panfotocoagulación con láser en edema macular diabético con el fotocoagulador Pascal® versus el láser de argón convencional.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde

Mahgoub MM, Macky TA.
PMID: 28693018
Ophthalmologica. 2017;238:16-20. doi: 10.1159/000477512. Epub 2017 Jul 11.

Objetivo: El objetivo de este estudio fue comparar el efecto de la panfotocoagulación (PFC) en el edema macular diabético (EMD) en pacientes con retinopatía diabética proliferativa (RDP) con el fotocoagulador Pascal® (FP) vs. un fotocoagulador con láser de argón...

Cite
Mahgoub MM, Macky TA. El efecto de la panfotocoagulación con láser en edema macular diabético con el fotocoagulador Pascal® versus el láser de argón convencional. Ophthalmologica. 2017;238:16-20doi: 10.1159/000477512.
Mahgoub, M. M., & Macky, T. A. (2017). El efecto de la panfotocoagulación con láser en edema macular diabético con el fotocoagulador Pascal® versus el láser de argón convencional. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 23816-20. https://doi.org/10.1159/000477512
Mahgoub, Mohamed M, and Macky, Tamer A. "El efecto de la panfotocoagulación con láser en edema macular diabético con el fotocoagulador Pascal® versus el láser de argón convencional." Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde vol. 238 (2017): 16-20. doi: https://doi.org/10.1159/000477512
Mahgoub MM, Macky TA. El efecto de la panfotocoagulación con láser en edema macular diabético con el fotocoagulador Pascal® versus el láser de argón convencional. Ophthalmologica. 2017;238:16-20. doi: 10.1159/000477512. Epub 2017 Jul 11. PMID: 28693018.
Copy Download .nbib Format: NLM
Pain or nociception? Subjective experience mediates the effects of acute noxious heat on autonomic responses - corrected and republished.

Pain

Mischkowski D, Palacios-Barrios EE, Banker L, Dildine TC, Atlas LY.
PMID: 31107415
Pain. 2019 Jun;160(6):1469-1481. doi: 10.1097/j.pain.0000000000001573.

Nociception reliably elicits an autonomic nervous system (ANS) response. Because pain and ANS circuitry interact on multiple spinal, subcortical, and cortical levels, it remains unclear whether autonomic responses are simply a reflexive product of noxious stimulation regardless of how...

Cite
Mischkowski D, Palacios-Barrios EE, Banker L, et al. Pain or nociception? Subjective experience mediates the effects of acute noxious heat on autonomic responses - corrected and republished. Pain. 2019;160(6):1469-1481doi: 10.1097/j.pain.0000000000001573.
Mischkowski, D., Palacios-Barrios, E. E., Banker, L., Dildine, T. C., & Atlas, L. Y. (2019). Pain or nociception? Subjective experience mediates the effects of acute noxious heat on autonomic responses - corrected and republished. Pain, 160(6), 1469-1481. https://doi.org/10.1097/j.pain.0000000000001573
Mischkowski, Dominik, et al. "Pain or nociception? Subjective experience mediates the effects of acute noxious heat on autonomic responses - corrected and republished." Pain vol. 160,6 (2019): 1469-1481. doi: https://doi.org/10.1097/j.pain.0000000000001573
Mischkowski D, Palacios-Barrios EE, Banker L, Dildine TC, Atlas LY. Pain or nociception? Subjective experience mediates the effects of acute noxious heat on autonomic responses - corrected and republished. Pain. 2019 Jun;160(6):1469-1481. doi: 10.1097/j.pain.0000000000001573. PMID: 31107415; PMCID: PMC6553960.
Copy Download .nbib Format: NLM
Exercise Science and the Vocalist.

Journal of voice : official journal of the Voice Foundation

Johnson AM, Sandage MJ.
PMID: 34238660
J Voice. 2021 Jul;35(4):668-677. doi: 10.1016/j.jvoice.2021.06.029. Epub 2021 Jul 05.

The application of exercise science training knowledge has been of growing interest to voice professionals. This tutorial, derived from the authors' invited presentations from the "Exercise and the Voice" Special Session at the 2018 Voice Foundation Symposium, proposes a...

Cite
Johnson AM, Sandage MJ. Exercise Science and the Vocalist. J Voice. 2021;35(4):668-677doi: 10.1016/j.jvoice.2021.06.029.
Johnson, A. M., & Sandage, M. J. (2021). Exercise Science and the Vocalist. Journal of voice : official journal of the Voice Foundation, 35(4), 668-677. https://doi.org/10.1016/j.jvoice.2021.06.029
Johnson, Aaron M, and Sandage, Mary J. "Exercise Science and the Vocalist." Journal of voice : official journal of the Voice Foundation vol. 35,4 (2021): 668-677. doi: https://doi.org/10.1016/j.jvoice.2021.06.029
Johnson AM, Sandage MJ. Exercise Science and the Vocalist. J Voice. 2021 Jul;35(4):668-677. doi: 10.1016/j.jvoice.2021.06.029. Epub 2021 Jul 05. PMID: 34238660; PMCID: PMC8524757.
Copy Download .nbib Format: NLM
Erratum: Validity and feasibility of the self-assessment vitiligo extent score among Egyptian patients.

Indian journal of dermatology, venereology and leprology

[No authors listed]
PMID: 34877835
Indian J Dermatol Venereol Leprol. 2021 Dec 01;1. doi: 10.25259/IJDVL_498_20_ER. Epub 2021 Dec 01.

No abstract available.

Cite
Erratum: Validity and feasibility of the self-assessment vitiligo extent score among Egyptian patients. Indian J Dermatol Venereol Leprol. 2021;1doi: 10.25259/IJDVL_498_20_ER.
(2021). Erratum: Validity and feasibility of the self-assessment vitiligo extent score among Egyptian patients. Indian journal of dermatology, venereology and leprology, 1. https://doi.org/10.25259/IJDVL_498_20_ER
"Erratum: Validity and feasibility of the self-assessment vitiligo extent score among Egyptian patients." Indian journal of dermatology, venereology and leprology vol. (2021): 1. doi: https://doi.org/10.25259/IJDVL_498_20_ER
Erratum: Validity and feasibility of the self-assessment vitiligo extent score among Egyptian patients. Indian J Dermatol Venereol Leprol. 2021 Dec 01;1. doi: 10.25259/IJDVL_498_20_ER. Epub 2021 Dec 01. PMID: 34877835.
Copy Download .nbib Format: NLM
Metoclopramide Nasal Spray (Gimoti) for Diabetic Gastroparesis.

JAMA

[No authors listed]
PMID: 34283185
JAMA. 2021 Jul 20;326(3):270-271. doi: 10.1001/jama.2020.26625.

No abstract available.

Cite
Metoclopramide Nasal Spray (Gimoti) for Diabetic Gastroparesis. JAMA. 2021;326(3):270-271doi: 10.1001/jama.2020.26625.
(2021). Metoclopramide Nasal Spray (Gimoti) for Diabetic Gastroparesis. JAMA, 326(3), 270-271. https://doi.org/10.1001/jama.2020.26625
"Metoclopramide Nasal Spray (Gimoti) for Diabetic Gastroparesis." JAMA vol. 326,3 (2021): 270-271. doi: https://doi.org/10.1001/jama.2020.26625
Metoclopramide Nasal Spray (Gimoti) for Diabetic Gastroparesis. JAMA. 2021 Jul 20;326(3):270-271. doi: 10.1001/jama.2020.26625. PMID: 34283185.
Copy Download .nbib Format: NLM
Trijardy XR-A New 3-Drug Combination for Type 2 Diabetes.

JAMA

[No authors listed]
PMID: 33320220
JAMA. 2020 Dec 15;324(23):2437-2438. doi: 10.1001/jama.2020.10406.

No abstract available.

Cite
Trijardy XR-A New 3-Drug Combination for Type 2 Diabetes. JAMA. 2020;324(23):2437-2438doi: 10.1001/jama.2020.10406.
(2020). Trijardy XR-A New 3-Drug Combination for Type 2 Diabetes. JAMA, 324(23), 2437-2438. https://doi.org/10.1001/jama.2020.10406
"Trijardy XR-A New 3-Drug Combination for Type 2 Diabetes." JAMA vol. 324,23 (2020): 2437-2438. doi: https://doi.org/10.1001/jama.2020.10406
Trijardy XR-A New 3-Drug Combination for Type 2 Diabetes. JAMA. 2020 Dec 15;324(23):2437-2438. doi: 10.1001/jama.2020.10406. PMID: 33320220.
Copy Download .nbib Format: NLM
Showing 1621 to 165 of 165 entries